GE HealthCare’s new Revolution Ascend platform represents a new platform-based solution with built-in scalability for onsite CT detector upgrades from a highly efficient 20 mm coverage system for routine scanning to a more advanced 40 mm coverage system that improves low contrast detectability. This design enables health care systems to invest in the clinical capabilities they need today, while also enabling growth in the future – all without replacing the gantry.
The platform also introduces True Enhance DL,1 which uses a dedicated Deep Neural Network (DNN) designed to generate deep learning-based 50 kev monochromatic-like images from single-energy CT images. It is designed to increase contrast resolution for confident diagnoses, even for challenging oncology cases and other exams. The AI-based solution provides clinicians a simple workflow and incredible image quality without a radiation penalty.
1. True Enhance DL is 510(k)-pending with the U.S. FDA. Not available for sale in the United States
